Kistler Tiffany Companies, LLC Vertex Pharmaceuticals Inc Transaction History

Kistler Tiffany Companies, LLC

$615 Million
Q2 2023

A detailed history of Kistler Tiffany Companies, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 1,443 shares of VRTX stock, worth $589,840. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,443

Previous 1,443 -0.0%

Holding current value

$589,840

Previous $454,000 11.67%

% of portfolio

0.08%

Previous 0.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $51,480 - $57,439	-188 Reduced 11.53%	1,443 $418,000
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $25,463 - $30,011	-115 Reduced 6.59%	1,631 $426,000
Q4 2021 Jan 25, 2022	BUY	$177.01 - $223.45 $2,655 - $3,351	15 Added 0.87%	1,746 $383,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $6,167 - $6,901	34 Added 2.0%	1,731 $314,000
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $69,183 - $81,585	-369 Reduced 17.86%	1,697 $342,000
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $131,043 - $152,749	633 Added 44.17%	2,066 $444,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $136,212 - $181,667	658 Added 84.9%	1,433 $339,000
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $37,836 - $44,858	148 Added 23.6%	775 $211,000
Q2 2020 Jul 20, 2020	SELL	$225.48 - $295.8 $12,626 - $16,564	-56 Reduced 8.2%	627 $182,000
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $11,469 - $12,909	69 Added 11.24%	683 $116,000
Q2 2019 Jul 22, 2019	BUY	$164.61 - $190.37 $2,139 - $2,474	13 Added 2.16%	614 $113,000
Q2 2018 Jul 17, 2018	SELL	$145.72 - $169.96 $9,034 - $10,537	-62 Reduced 9.35%	601 $102,000
Q1 2018 Apr 06, 2018	BUY	$151.6 - $177.13 $1,970 - $2,302	13 Added 2.0%	663 $108,000
Q4 2017 Jan 11, 2018	SELL	$137.28 - $155.55 $2,059 - $2,333	-15 Reduced 2.26%	650 $97,000
Q3 2017 Oct 19, 2017	BUY	$148.13 - $162.24 $98,506 - $107,889	665	665 $101,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.

Account

Kistler Tiffany Companies, LLC Vertex Pharmaceuticals Inc Transaction History